SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-20-000037
Filing Date
2020-04-02
Accepted
2020-04-02 16:32:37
Documents
6
Period of Report
2020-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo20200402-8k.htm 8-K 46144
2 EXHIBIT 10.1 lumo20200402-8kxex101.htm EX-10.1 136966
3 EXHIBIT 10.2 lumo20200402-8kxex102.htm EX-10.2 152220
4 EXHIBIT 99.1 lumo20200402-8kxex991.htm EX-99.1 11713
5 EXHIBIT 99.2 lumo20200402-8kxex992.htm EX-99.2 14555
6 lumospharmalogo.jpg GRAPHIC 17984
  Complete submission text file 0001126234-20-000037.txt   382447
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 20769428
SIC: 2834 Pharmaceutical Preparations